Marine Brominated Tyrosine Alkaloids as Promising Inhibitors of SARS-CoV-2
There have been more than 150 million confirmed cases of SARS-CoV-2 since the beginning of the pandemic in 2019. By June 2021, the mortality from such infections approached 3.9 million people. Despite the availability of a number of vaccines which provide protection against this virus, the evolution...
Main Authors: | Amr El-Demerdash, Afnan Hassan, Tarek Mohamed Abd El-Aziz, James D. Stockand, Reem K. Arafa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/20/6171 |
Similar Items
-
New N-Alkylated Heterocyclic Compounds as Prospective NDM1 Inhibitors: Investigation of In Vitro and In Silico Properties
by: Yassine Kaddouri, et al.
Published: (2022-06-01) -
Bioactive Bromotyrosine-Derived Alkaloids from the Polynesian Sponge Suberea ianthelliformis
by: Amr El-Demerdash, et al.
Published: (2018-04-01) -
QSAR, ADME-Tox, molecular docking and molecular dynamics simulations of novel selective glycine transporter type 1 inhibitors with memory enhancing properties
by: Mohamed El fadili, et al.
Published: (2023-02-01) -
Oxidative functionalization of triterpenes isolated from Euphorbia resinifera latex: Semisynthesis, ADME-Tox, molecular docking, and molecular dynamics simulations
by: Imane Yamari, et al.
Published: (2023-12-01) -
Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19)
by: Amr El-Demerdash, et al.
Published: (2021-03-01)